Krystal Biotech, Inc. (1KRYS)
MTA
Closed
Oct 2, 2026
Day's Range
295.1052 wk Range
138.65Overview - 1KRYS - Krystal Biotech, Inc.
Key Statistics
Valuation
Enterprise Value
7.02B
P/E (Trailing)
‪42.89‬
PEG Ratio
‪1.09‬
Price / Sales (TTM)
‪20.23‬
Price / Book
‪7.46‬
EV / EBITDA
‪40.17‬
Profitability
Gross Margin
‪94.60%‬
Profit Margin
‪54.81%‬
Operating Margin
‪48.99%‬
Return on Assets
‪9.36%‬
Return on Equity
‪20.12%‬
Ownership
Shares Outstanding
29.59M
Float
23.61M
Held by Insiders
‪10.65%‬
Held by Institutions
‪102.52%‬
Price stats
Beta
‪0.53‬
50-Day Avg
‪297.73‬
200-Day Avg
‪258.66‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1KRYS - Krystal Biotech, Inc.
Peers - 1KRYS - Krystal Biotech, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1KRYSMTAKrystal Biotech, Inc.6.14BMarket Cap+53.60%52-week change42.89P/E (Trailing)‪54.81%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated Common Stock107.27BMarket Cap+27.72%52-week change30.40P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals, Inc.73.52BMarket Cap+30.66%52-week change19.47P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals, Inc.45.81BMarket Cap-73.35%52-week change43.84P/E (Trailing)‪16.12%‬Profit Margin
- 1INSMMTAInsmed Incorporated30.28BMarket Cap-19.46%52-week change-16.17P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-40.10%52-week change42.38P/E (Trailing)‪13.01%‬Profit Margin
- 1INCYMTAIncyte Corp.17.89BMarket Cap+32.92%52-week change15.77P/E (Trailing)‪27.70%‬Profit Margin
Profile Summary - 1KRYS - Krystal Biotech, Inc.
About
Krystal Biotech, Inc. is a commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing genetic medicines for serious and rare diseases. Its lead product, VYJUVEK, is a redosable gene therapy approved for dystrophic epidermolysis bullosa, a rare inherited skin disorder.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
